ResearcherMassachusetts Institute of TechnologyNo recent work listed

Alissandra L. Hillis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6667-1291; OpenAlex author ID A5046552202. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper

Papers 1

PKM2 is not required for pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s40170-018-0188-1 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Laura V. Danai · 1 shared paper, 2018 · strength 0.09
- Paper PKM2 is not required for pancreatic ductal adenocarcinoma. DOI 10.1186/s40170-018-0188-1 ↗
Allison N. Lau · 1 shared paper, 2018 · strength 0.09
- Paper PKM2 is not required for pancreatic ductal adenocarcinoma. DOI 10.1186/s40170-018-0188-1 ↗
Matthew G. Vander Heiden · 1 shared paper, 2018 · strength 0.09
- Paper PKM2 is not required for pancreatic ductal adenocarcinoma. DOI 10.1186/s40170-018-0188-1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.